SHANNA MACCLAREN: Open Payments
NPI 1407322985 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 33 payments from 15 companies in 2025. Trend: 2023 $1,231 · 2024 $1,895 · 2025 $1,485
Food & beverage: $1,485
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $318 |
| AstraZeneca Pharmaceuticals LP | 2 | $227 |
| E.R. Squibb & Sons, L.L.C. | 2 | $220 |
| ABBVIE INC. | 8 | $153 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $116 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
Products named: COBENFY, Wegovy, Ozempic, BREZTRI, Auvelity, NUCALA, AIRSUPRA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
